Haiyan Zhang
Longhua, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.
Journal: Journal of autoimmunity
Published: September 26, 2022
Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis.
Journal: Annals of palliative medicine
Published: April 28, 2021
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.
Journal: Cellular & molecular immunology
Published: October 18, 2017
How the biliary tree maintains immune tolerance?
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: May 15, 2017
A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
Journal: Hepatology (Baltimore, Md.)
Published: March 05, 2017
A genome-wide association study identifies six novel risk loci for primary biliary cholangitis.
Journal: Nature communications
Published: October 06, 2016
Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.
Journal: PloS one
Published: March 25, 2016
A Common Variant in CLDN14 is Associated with Primary Biliary Cirrhosis and Bone Mineral Density.
Journal: Scientific reports
Published: October 13, 2015
The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis.
Journal: Clinical reviews in allergy & immunology
Published: September 29, 2015
Hypoxia-inducible factor-2α promotes hepatocyte apoptosis during cholestasis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 22, 2015
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.
Journal: Journal of autoimmunity
Published: June 19, 2015
Last Updated: 09/26/2026